Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study

N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation

(2017) Emma Svennberg et al.   HEART

Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design

(2016) Johan Engdahl et al.   EUROPACE

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

(2016) Ziad Hijazi et al.   EUROPEAN HEART JOURNAL

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study

(2016) Johan Engdahl et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study

(2015) E. Svennberg et al.   CIRCULATION

Adverse prognosis of incidentally detected ambulatory atrial fibrillation

(2014) Carlos Martinez et al.   THROMBOSIS AND HAEMOSTASIS

Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population

(2013) Johan Engdahl et al.   CIRCULATION

Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation

(2012) Ziad Hijazi et al.   CIRCULATION

N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation

(2009) Kristen K. Patton et al.   CIRCULATION